TL;DR: Indee Labs is a Y Combinator Winter 2017 startup Enabling T cell immunotherapy discovery, development and manufacturing, currently active with a team of 5.
Enabling T cell immunotherapy discovery, development and manufacturing
Last verified:
Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.
Built by LemStudio
Yes. Indee Labs was funded by Y Combinator in the Winter 2017 batch. Enabling T cell immunotherapy discovery, development and manufacturing
Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor…
Indee Labs was part of Y Combinator's Winter 2017 batch.
Indee Labs has a team of 5 people according to Y Combinator's directory.
Indee Labs is currently listed as Active with a team of 5 in Y Combinator's directory.
Loading interactive view…